TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

covid-19-vaccine
Play
JIM CRAMER

Mad Money Recap With Jim Cramer: Science Is Winning

  • By Scott Rutt
  • Nov 24, 2020 8:46 AM EST
PRESS RELEASES

Sangamo Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 5, 2021 8:00 AM EST
PRESS RELEASES

Pfizer And Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels In 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy

  • By Business Wire
  • Dec 7, 2020 7:00 AM EST
covid-19-vaccine
JIM CRAMER

Mad Money Recap With Jim Cramer: Science Is Winning

  • By Scott Rutt
  • Nov 24, 2020 8:46 AM EST
PRESS RELEASES

Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

  • By Business Wire
  • Nov 5, 2020 8:00 AM EST
PRESS RELEASES

Sangamo Therapeutics Announces Third Quarter 2020 Conference Call And Webcast

  • By Business Wire
  • Oct 28, 2020 4:15 PM EDT
PRESS RELEASES

Pfizer And Sangamo Dose First Participant In Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment

  • By Business Wire
  • Oct 7, 2020 6:45 AM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

  • By Business Wire
  • Sep 28, 2020 8:30 AM EDT
PRESS RELEASES

Sangamo Therapeutics Appoints Kenneth Hillan To Its Board Of Directors

  • By Business Wire
  • Sep 11, 2020 8:30 AM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

  • By Business Wire
  • Sep 2, 2020 4:15 PM EDT
PRESS RELEASES

Sangamo Therapeutics To Present At The 2020 Wedbush PacGrow Healthcare Conference

  • By Business Wire
  • Aug 10, 2020 8:30 AM EDT
PRESS RELEASES

Sangamo Announces Global Collaboration With Novartis To Develop Genomic Medicines For Autism And Other Neurodevelopmental Disorders

  • By Business Wire
  • Jul 30, 2020 7:00 AM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Second Quarter 2020 Conference Call And Webcast

  • By Business Wire
  • Jul 29, 2020 4:15 PM EDT
PRESS RELEASES

Sangamo Announces R&D Organization Changes

  • By Business Wire
  • Jun 24, 2020 8:00 AM EDT
PRESS RELEASES

Pfizer And Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels And No Bleeding Events Or Factor Usage In 3e13 Vg/kg Cohort Following Giroctocogene Fitelparvovec (SB-525) Gene Therapy

  • By Business Wire
  • Jun 18, 2020 9:00 AM EDT
PRESS RELEASES

Pfizer And Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels And No Bleeding Events Or Factor Usage In 3e13 Vg/kg Cohort Following Giroctocogene Fitelparvovec (SB-525) Gene Therapy

  • By Business Wire
  • Jun 18, 2020 9:00 AM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Participation At The Jefferies Virtual Healthcare Conference

  • By Business Wire
  • May 29, 2020 9:00 AM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Virtual Format For 2020 Annual Meeting

  • By Business Wire
  • May 7, 2020 5:15 PM EDT
PRESS RELEASES

Sangamo Therapeutics Announces First Quarter 2020 Conference Call And Webcast

  • By Business Wire
  • May 4, 2020 4:15 PM EDT
PRESS RELEASES

Sangamo Therapeutics Announces Presentations At 2020 Annual Meeting Of The American Society Of Gene & Cell Therapy

  • By Business Wire
  • Apr 28, 2020 4:30 PM EDT
Biogen Shares Climb on Earnings Beat, CEO Departure
INVESTING

Biogen Reports Better-Than-Expected Earnings - Stock Lower

  • By Dan Weil
  • Apr 22, 2020 8:32 AM EDT
PRESS RELEASES

Mogrify And Sangamo Announce Collaboration And Exclusive License Agreement For Mogrify's IPSC- And ESC-derived Regulatory T Cells

  • By Business Wire
  • Apr 21, 2020 7:00 AM EDT
PRESS RELEASES

Sangamo Appoints D. Mark McClung As Executive Vice President And Chief Business Officer

  • By Business Wire
  • Apr 17, 2020 8:30 AM EDT
PRESS RELEASES

Sangamo Announces Closing Of Biogen Collaboration Agreement

  • By Business Wire
  • Apr 9, 2020 8:00 AM EDT
Jim Cramer Lead
JIM CRAMER

Fight the Fear: Cramer's 'Mad Money' Recap (Thursday 3/5/20)

  • By Scott Rutt
  • Mar 5, 2020 9:06 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.